Vetoquinol Overview

  • Year Founded
  • 1933

Year Founded

  • Status
  • Public

  • Employees
  • 2,486

Employees

  • Stock Symbol
  • VETO

Stock Symbol

  • Investments
  • 12

  • Share Price
  • $94.68
  • (As of Thursday Closing)

Vetoquinol General Information

Description

Vetoquinol SA specializes in the research, development, production and marketing of veterinary drugs and products for pets and livestock (cattle, pigs, poultry, etc.). The group's activity is organized around 4 product families: antibiotics; anti-inflammatories; cardiology and nephrology treatments; and other: anti-parasitics, vaccines, and nutritional products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 34 rue du chêne Sainte Anne
  • Magny-Vernois
  • 70204 Lure
  • France
+33 03
Primary Industry
Other Agriculture
Other Industries
Other Consumer Non-Durables
Other Services (B2C Non-Financial)
Stock Exchange
PAR
Vertical(s)
Corporate Office
  • 34 rue du chêne Sainte Anne
  • Magny-Vernois
  • 70204 Lure
  • France
+33 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vetoquinol Stock Performance

As of 19-Nov-2026, Vetoquinol’s stock price is $94.68. Its current market cap is $1.1B with 11.6M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$94.68 $94.98 $76.43 - $108.59 $1.1B 11.6M 7.96K $6.35

Vetoquinol Financials Summary

As of 30-Jun-2026, Vetoquinol has a trailing 12-month revenue of $615M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 706,218 961,599 768,060 1,248,170
Revenue 615,157 592,977 583,463 572,711
EBITDA 136,523 124,866 115,519 118,002
Net Income 73,294 64,702 63,503 60,120
Total Assets 879,894 896,977 774,324 765,193
Total Debt 14,102 17,962 21,980 19,486
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vetoquinol Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vetoquinol‘s full profile, request access.

Request a free trial

Vetoquinol Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Vetoquinol SA specializes in the research, development, production and marketing of veterinary drugs and products for pe
Other Agriculture
Lure, France
2,486 As of 2025

Sydney, Australia

Dublin, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vetoquinol Competitors (4)

One of Vetoquinol’s 4 competitors is Virbac Australia, a Corporation company based in Sydney, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Virbac Australia Corporation Sydney, Australia
MSD Animal Health Corporation Dublin, Ireland
Zoetis Corporation Parsippany, NJ
Phibro Animal Health Formerly PE-Backed Teaneck, NJ
To view Vetoquinol’s complete competitors history, request access »

Vetoquinol Patents

Vetoquinol Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-245953-S Cardboard packaging box Active 12-May-2025
EP-4816400-A1 Anti-canine interleukine-4-receptor alpha (il-4r-alpha) antibodies and the uses thereof Pending 30-Nov-2023
WO-2025114614-A1 Anti-canine interleukine-4-receptor alpha (il-4rα) antibodies and the uses thereof Inactive 30-Nov-2023
EP-4538282-A1 Synthesis of emodepside Inactive 13-Oct-2023
EP-4791753-A1 Synthesis of emodepside Pending 13-Oct-2023 C07K11/02
To view Vetoquinol’s complete patent history, request access »

Vetoquinol Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vetoquinol Investments & Acquisitions (12)

Vetoquinol’s most recent deal was a Merger/Acquisition with Vetoquinol Japan. The deal was made on 26-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vetoquinol Japan 26-Jan-2022 Merger/Acquisition Distributors/Wholesale
Elanco (Drontal and Profender European Economic Area and UK Rights) 12-Feb-2020 Corporate Asset Purchase Buildings and Property
Clarion Biociências 16-Apr-2019 Merger/Acquisition Other Commercial Products
VetIMPRESS 06-Sep-2018 Merger/Acquisition Business/Productivity Software
Plant Advanced Technologies PAT 13-Nov-2017 PIPE Other Commercial Services
You’re viewing 5 of 12 investments and acquisitions. Get the full list »

Vetoquinol ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

27.24 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Vetoquinol’s complete esg history, request access »

Vetoquinol Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Vetoquinol Japan Tokyo, Japan 2015
VetIMPRESS Moneymore, United Kingdom 2010
Vetoquinol International Magny-Vernois, France 2007
Vetoquinol Scandinavia Aastorp, Sweden 2004

Vetoquinol FAQs

  • When was Vetoquinol founded?

    Vetoquinol was founded in 1933.

  • Where is Vetoquinol headquartered?

    Vetoquinol is headquartered in Lure, France.

  • What is the size of Vetoquinol?

    Vetoquinol has 2,486 total employees.

  • What industry is Vetoquinol in?

    Vetoquinol’s primary industry is Other Agriculture.

  • Is Vetoquinol a private or public company?

    Vetoquinol is a Public company.

  • What is Vetoquinol’s stock symbol?

    The ticker symbol for Vetoquinol is VETO.

  • What is the current stock price of Vetoquinol?

    As of 19-Nov-2026 the stock price of Vetoquinol is $94.68.

  • What is the current market cap of Vetoquinol?

    The current market capitalization of Vetoquinol is $1.1B.

  • What is Vetoquinol’s current revenue?

    The trailing twelve month revenue for Vetoquinol is $615M.

  • Who are Vetoquinol’s competitors?

    Virbac Australia, MSD Animal Health, Zoetis, and Phibro Animal Health are competitors of Vetoquinol.

  • What is Vetoquinol’s annual earnings per share (EPS)?

    Vetoquinol’s EPS for 12 months was $6.35.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process